Showing 12 authorised medicines
Medicine Active substance Licence holder Status
Ranexa 375 mg prolonged-release tablets EU/1/08/462/1,2,7,8
Ranolazine
Menarini International Operations Luxembourg S.A.
—
Ranexa 500 mg prolonged-release tablets EU/1/08/462/3,4,9,10
Ranolazine
Menarini International Operations Luxembourg S.A.
—
Ranexa 750 mg prolonged-release tablets EU/1/08/462/5,6,11,12
Ranolazine
Menarini International Operations Luxembourg S.A.
—
Ranolazine Accord 375 mg prolonged-release tablets PA2315/259/001
Ranolazine
Accord Healthcare Ireland Ltd.
Not marketed
Ranolazine Accord 500 mg prolonged-release tablet PA2315/259/002
Ranolazine
Accord Healthcare Ireland Ltd.
Not marketed
Ranolazine Accord 750 mg prolonged-release tablets PA2315/259/003
Ranolazine
Accord Healthcare Ireland Ltd.
Not marketed
Ranolazine Clonmel 375 mg prolonged-release tablets PA0126/356/001
Ranolazine
Clonmel Healthcare Ltd
Marketed
Ranolazine Clonmel 500 mg prolonged-release tablets PA0126/356/002
Ranolazine
Clonmel Healthcare Ltd
Marketed
Ranolazine Clonmel 750 mg prolonged-release tablets PA0126/356/003
Ranolazine
Clonmel Healthcare Ltd
Marketed
Ranolazine Krka 375 mg prolonged-release tablets PA1347/109/001
Ranolazine
KRKA, d.d., Novo mesto
Marketed
Ranolazine Krka 500 mg prolonged-release tablets PA1347/109/002
Ranolazine
KRKA, d.d., Novo mesto
Marketed
Ranolazine Krka 750 mg prolonged-release tablets PA1347/109/003
Ranolazine
KRKA, d.d., Novo mesto
Marketed
Cite this database
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).
Copy citation
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.